M.-C. Carrillo

612 total citations
9 papers, 540 citations indexed

About

M.-C. Carrillo is a scholar working on Molecular Biology, Pharmacology and Complementary and alternative medicine. According to data from OpenAlex, M.-C. Carrillo has authored 9 papers receiving a total of 540 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Pharmacology and 2 papers in Complementary and alternative medicine. Recurrent topics in M.-C. Carrillo's work include Cholinesterase and Neurodegenerative Diseases (4 papers), Mitochondrial Function and Pathology (3 papers) and Medicinal Plants and Neuroprotection (2 papers). M.-C. Carrillo is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (4 papers), Mitochondrial Function and Pathology (3 papers) and Medicinal Plants and Neuroprotection (2 papers). M.-C. Carrillo collaborates with scholars based in Japan, Canada and Argentina. M.-C. Carrillo's co-authors include Sachiko Kanai, Kenichi Kitani, M. Nokubo, Gwen O. Ivy, Wakako Maruyama, Yukihiro Akao, Kenichi Kitani, Makoto Naoi, Yuko Sato and K. Miyasaka and has published in prestigious journals such as Life Sciences, Neurotoxicology and Teratology and Biogerontology.

In The Last Decade

M.-C. Carrillo

9 papers receiving 522 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M.-C. Carrillo Japan	8	182	174	158	108	83	9	540
Zegang Ma China	17	213 1.2×	146 0.8×	187 1.2×	171 1.6×	110 1.3×	32	664
M. Nokubo Japan	9	168 0.9×	67 0.4×	105 0.7×	58 0.5×	67 0.8×	15	455
Khan Shoeb Zafar India	9	157 0.9×	119 0.7×	97 0.6×	48 0.4×	63 0.8×	10	524
M. Hiramatsu Japan	11	142 0.8×	46 0.3×	126 0.8×	77 0.7×	108 1.3×	20	503
Yanier Núñez-Figueredo Cuba	16	217 1.2×	78 0.4×	154 1.0×	111 1.0×	132 1.6×	57	618
Salema B. Abul Khair United Arab Emirates	7	163 0.9×	200 1.1×	97 0.6×	65 0.6×	126 1.5×	7	529
Ifeoma N. Odunze United States	8	204 1.1×	207 1.2×	177 1.1×	51 0.5×	161 1.9×	8	643
Jardel Gomes Villarinho Brazil	16	167 0.9×	98 0.6×	248 1.6×	173 1.6×	173 2.1×	19	673
Michael Gassen Israel	15	280 1.5×	433 2.5×	370 2.3×	87 0.8×	140 1.7×	18	950
Gianni Benzi Italy	10	330 1.8×	95 0.5×	146 0.9×	181 1.7×	280 3.4×	21	884

Countries citing papers authored by M.-C. Carrillo

Since Specialization

Citations

This map shows the geographic impact of M.-C. Carrillo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.-C. Carrillo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.-C. Carrillo more than expected).

Fields of papers citing papers by M.-C. Carrillo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.-C. Carrillo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.-C. Carrillo. The network helps show where M.-C. Carrillo may publish in the future.

Co-authorship network of co-authors of M.-C. Carrillo

This figure shows the co-authorship network connecting the top 25 collaborators of M.-C. Carrillo. A scholar is included among the top collaborators of M.-C. Carrillo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.-C. Carrillo. M.-C. Carrillo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Kitani, Kenichi, Sachiko Kanai, K. Miyasaka, M.-C. Carrillo, & Gwen O. Ivy. (2005). Dose-dependency of Life Span Prolongation of F344/DuCrj Rats Injected with (−)deprenyl. Biogerontology. 6(5). 297–302. 10 indexed citations

Maruyama, Wakako, et al.. (2002). Neuroprotection by propargylamines in Parkinson's disease. Neurotoxicology and Teratology. 24(5). 675–682. 132 indexed citations

Carrillo, M.-C., et al.. (2001). Insulin hyperresponsiveness in partially hepatectomized diabetic rats. Life Sciences. 68(12). 1417–1426. 5 indexed citations

Kitani, Kenichi, et al.. (2000). Common properties for propargylamines of enhancing superoxide dismutase and catalase activities in the dopaminergic system in the rat: implications for the life prolonging effect of (–)deprenyl. PubMed. 139–156. 20 indexed citations

Carrillo, M.-C., Kenichi Kitani, Sachiko Kanai, et al.. (1996). Long term treatment with (−)deprenyl reduces the optimal dose as well as the effective dose range for increasing antioxidant enzyme activities in old mouse brain. Life Sciences. 59(13). 1047–1057. 16 indexed citations

Carrillo, M.-C., Kenichi Kitani, Sachiko Kanai, et al.. (1994). (-)Deprenyl increases activities of superoxide dismutase and catalase in certain brain regions in old male mice. Life Sciences. 54(14). 975–981. 40 indexed citations

Carrillo, M.-C., Sachiko Kanai, Yuko Sato, et al.. (1993). The optimal dosage of (−)deprenyl for increasing superoxide dismutase activities in several brain regions decreases with age in male Fischer 344 rats. Life Sciences. 52(24). 1925–1934. 36 indexed citations

Carrillo, M.-C., Kenichi Kitani, Sachiko Kanai, Yuko Sato, & Gwen O. Ivy. (1992). The ability of (−)deprenyl to increase superoxide dismutase activities in the rat is tissue and brain region selective. Life Sciences. 50(25). 1985–1992. 50 indexed citations

Carrillo, M.-C., Sachiko Kanai, M. Nokubo, & Kenichi Kitani. (1991). (−) deprenyl induces activities of both superoxide dismutase and catalase but not of glutathione peroxidase in the striatum of young male rats. Life Sciences. 48(6). 517–521. 231 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact